DSIP
DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide that promotes deep delta-wave (slow-wave) sleep and buffers stress-driven cortisol.
Total Price
฿900
For research & laboratory use only. Not for human consumption.
Half-Life
~30 minutes
Administration Route
Subcutaneous injection or intravenous
Deep Sleep Induction
Delta Sleep-Inducing Peptide increases slow-wave sleep duration
Stress Buffering
Reduces cortisol response to acute and chronic stress
Circadian Regulation
Modulates sleep architecture without next-day sedation
Mechanism of Action
Scientific Research
Experientia (1994)
Peptides (1988)
Regul Pept (1989)
Why Researchers Choose DSIP for Sleep
Sleep is not a single uniform state. It cycles through NREM stages 1 to 3 and REM, and the value of a given night depends heavily on how much slow-wave sleep it contains. Stage 3 NREM, known as slow-wave sleep (SWS), is defined by high-amplitude delta waves (0.5 to 4 Hz) and is the most physiologically restorative stage:
- The main window for growth-hormone secretion, with roughly 70 to 80% of daily GH release occurring during SWS
- Consolidation of declarative memory
- Cellular repair and immune activation
- The natural low point (nadir) of the cortisol curve
- Peak glymphatic clearance of metabolic waste from the brain
- The nightly dip in blood pressure and sympathetic (fight-or-flight) tone
Delta Sleep-Inducing Peptide (DSIP) is studied specifically because it appears to promote and deepen SWS, in contrast to common sleep aids that shorten sleep latency but can blunt slow-wave sleep.
Multi-System Regulatory Effects
HPA axis: DSIP dampens excessive cortisol release after psychological or physical stress. The pattern in the literature is one of normalising the stress response rather than globally suppressing it, since adrenal steroidogenesis under resting conditions is not meaningfully affected.
GH axis: DSIP modulates somatotroph activity, and several reports describe altered GH pulsatility. Given how tightly GH release is coupled to slow-wave sleep, a sleep-active peptide influencing this axis is mechanistically coherent.
NK cell activity: In some models DSIP modulates natural killer cell cytotoxicity, hinting at a link between sleep quality, immune function, and DSIP signalling.
Antinociception: DSIP shows weak but reproducible antinociceptive effects in rodent pain models, possibly mediated through opioid-system modulation.
Research Applications
- Slow-wave sleep architecture and sleep-quality research
- HPA axis dysregulation models
- Stress physiology and cortisol reactivity
- Sleep-associated GH secretion studies
- Immune-sleep interaction research
Reconstitution and Storage
Reconstitution: use bacteriostatic water to a low working concentration; swirl gently, do not shake. DSIP is prone to aggregation and cross-linking, so avoid acidic conditions and repeated freeze-thaw cycles. After reconstitution: keep refrigerated and use the reconstituted solution promptly.
For research purposes only. Not for human consumption.
Dosing at a Glance
Route
Subcutaneous injection or intravenous
Frequency
Once daily (before sleep)
Typical research dose
100–250 mcg
Opens the calculator with this peptide preselected. Research reference only.
Product FAQs
Stacks Well With
Related Products
Selank
Selank is a synthetic tuftsin-analogue heptapeptide developed in Russia, studied as a non-sedating anxiolytic and nootropic that raises BDNF.
Pinealon
Pinealon (Glu-Asp-Arg, EDR) is a Khavinson short-peptide bioregulator studied for neuroprotection, melatonin support and reduced neuronal oxidative stress.